Purchase Order 75F40122P00202
- Not listed
- This $164,555.50 firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian government agency, to Emulate Inc., a small business contractor, for the procurement of two Zoe Culture Modules and two Orb Hub Modules of the Human Emulation System. The award, made under a small business set-aside, supports the FDA's regulatory science initiatives and efforts to advance non-animal testing approaches. Emulate Inc. has a long history of providing...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- The Department of Health and Human Services Food and Drug Administration awarded a $213,100 firm fixed price purchase order to Emulate Inc. of Boston, Massachusetts. The contract will provide a human emulation system including an ORB-HM1 hub module, two used ZOE-CM2 culture modules, and one new ZOE-CM2 culture module with a one year warranty. Additionally, a service agreement will cover maintenance of the three used items for one year. Per the sole source solicitation, Emulate will satisfy the...
- The U.S. Food and Drug Administration (FDA) awarded a $90,529 firm-fixed-price purchase order contract to Emulate Inc., a biotechnology company specializing in organ-on-chip technology, for the provision of a Zoe Culture Module base year and four option years of preventative maintenance services for two Zoe Culture Modules and two Orb Hub Modules. This contract was awarded under solicitation FDA-RFQ-CVM-2023-116804 and does not have a set-aside designation. Emulate, located in Boston,...
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip technology, was awarded a $145,260 firm fixed-price purchase order by the Food and Drug Administration on August 1, 2024. The contract calls for delivery of the CHIP-S1 Stretchable Chip (catalog number 10231-2) with an ultimate completion date of August 31, 2024. This award was designated as a Total Small Business set-aside, recognizing Emulate's status as a small business entity. The Food and Drug Administration, a...
- The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small...
- This firm fixed price purchase order for $144,800 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Emulate Inc., doing business as Emulate, for the delivery of four ZOE culture module updates from Configuration 1 to Configuration 2. No set-aside designation was used for this procurement. Place of performance will be Emulate's facilities in Boston, Massachusetts. Emulate is a for-profit...
- The Department of Health and Human Services' Food and Drug Administration awarded a $104,500 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the procurement of five liver human emulation system 24 pack quad liver chip kits. The place of performance will be Emulate's facilities in Boston, Massachusetts. The period of performance is one year, from June 27, 2023 through June 26, 2024. This contract has a total small business set aside designation. The liver chip kits...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order contract to Emulate Inc., a for-profit small business, with a potential value of $218,100.00. The contract is for the delivery of two (2) each of the Human Emulation System ZOE Culture Module 2 and two (2) each of the Orb Hub Module. Emulate's organ-on-a-chip technology is designed to model human biology and supports federal initiatives in areas like personalized medicine, biosurveillance, infectious disease research, radiation health effects, and alternatives to animal testing. This award is part of Emulate's ongoing provision of human emulation systems, modules, chips, reagents, and maintenance services to various U.S. government agencies, including the Department of Defense, Department of the Army, Department of the Air Force, Department of Veterans Affairs, and the Uniformed Services University of the Health Sciences.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $218.1k | 6/28/22 |